Kenichi Iwai

793 total citations
29 papers, 446 citations indexed

About

Kenichi Iwai is a scholar working on Molecular Biology, Cell Biology and Pharmacology. According to data from OpenAlex, Kenichi Iwai has authored 29 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 8 papers in Cell Biology and 5 papers in Pharmacology. Recurrent topics in Kenichi Iwai's work include Microtubule and mitosis dynamics (6 papers), Cancer therapeutics and mechanisms (6 papers) and DNA Repair Mechanisms (4 papers). Kenichi Iwai is often cited by papers focused on Microtubule and mitosis dynamics (6 papers), Cancer therapeutics and mechanisms (6 papers) and DNA Repair Mechanisms (4 papers). Kenichi Iwai collaborates with scholars based in Japan, United States and Norway. Kenichi Iwai's co-authors include Akihiro Ohashi, Momoko Ohori, Masanori Okaniwa, Tomohiro Kawamoto, Tomoyasu Ishikawa, Goro Yoshizaki, Surintorn Boonanuntanasarn, Toshio Takeuchi, Takaharu Hirayama and Tadahiro Nambu and has published in prestigious journals such as Nature Communications, PLoS ONE and Journal of Medicinal Chemistry.

In The Last Decade

Kenichi Iwai

27 papers receiving 436 citations

Peers

Kenichi Iwai
Susan Peng United States
Nhung Nguyen United States
Edward Little United States
Kenichi Iwai
Citations per year, relative to Kenichi Iwai Kenichi Iwai (= 1×) peers Elena Poser

Countries citing papers authored by Kenichi Iwai

Since Specialization
Citations

This map shows the geographic impact of Kenichi Iwai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenichi Iwai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenichi Iwai more than expected).

Fields of papers citing papers by Kenichi Iwai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenichi Iwai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenichi Iwai. The network helps show where Kenichi Iwai may publish in the future.

Co-authorship network of co-authors of Kenichi Iwai

This figure shows the co-authorship network connecting the top 25 collaborators of Kenichi Iwai. A scholar is included among the top collaborators of Kenichi Iwai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenichi Iwai. Kenichi Iwai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Iwai, Kenichi, Tadahiro Nambu, Yukie Kashima, et al.. (2021). A CDC7 inhibitor sensitizes DNA-damaging chemotherapies by suppressing homologous recombination repair to delay DNA damage recovery. Science Advances. 7(21). 19 indexed citations
2.
Iwai, Kenichi, et al.. (2020). Breeding of <i>Aspergillus luchuensis</i> with high acidic protease production and brewing tests for sweet potato <i>shochu</i>. JOURNAL OF THE BREWING SOCIETY OF JAPAN. 115(1). 54–61.
3.
Kurasawa, Osamu, T. Miyazaki, Misaki Homma, et al.. (2020). Discovery of a Novel, Highly Potent, and Selective Thieno[3,2-d]pyrimidinone-Based Cdc7 Inhibitor with a Quinuclidine Moiety (TAK-931) as an Orally Active Investigational Antitumor Agent. Journal of Medicinal Chemistry. 63(3). 1084–1104. 16 indexed citations
4.
Mizutani, Osamu, et al.. (2019). Effect of pepA deletion and overexpression in Aspergillus luchuensis on sweet potato shochu brewing. Journal of Bioscience and Bioengineering. 128(4). 456–462. 3 indexed citations
5.
Iwai, Kenichi, Tadahiro Nambu, Jie Yu, et al.. (2019). Abstract A093: Potential combination partners for a novel CDC7-selective Inhibitor, TAK-931. Molecular Cancer Therapeutics. 18(12_Supplement). A093–A093. 1 indexed citations
6.
Iwai, Kenichi, et al.. (2019). Novel fermented products made from sweet potato-<i>shochu</i> distillery by-products reduces body fat and serum cholesterol in mice.. JOURNAL OF THE BREWING SOCIETY OF JAPAN. 114(5). 294–301. 1 indexed citations
7.
Kurasawa, Osamu, Yuya Oguro, T. Miyazaki, et al.. (2017). Identification of a new class of potent Cdc7 inhibitors designed by putative pharmacophore model: Synthesis and biological evaluation of 2,3-dihydrothieno[3,2-d]pyrimidin-4(1H)-ones. Bioorganic & Medicinal Chemistry. 25(7). 2133–2147. 14 indexed citations
8.
Kurasawa, Osamu, Misaki Homma, Yuya Oguro, et al.. (2017). 2-Aminomethylthieno[3,2-d]pyrimidin-4(3H)-ones bearing 3-methylpyrazole hinge binding moiety: Highly potent, selective, and time-dependent inhibitors of Cdc7 kinase. Bioorganic & Medicinal Chemistry. 25(14). 3658–3670. 10 indexed citations
9.
Hirayama, Takaharu, Masanori Okaniwa, Hiroshi Banno, et al.. (2016). Design and synthesis of fused bicyclic inhibitors targeting the L5 loop site of centromere-associated protein E. Bioorganic & Medicinal Chemistry Letters. 26(17). 4296–4300. 2 indexed citations
10.
Ohashi, Akihiro, Momoko Ohori, Kenichi Iwai, et al.. (2015). A Novel Time-Dependent CENP-E Inhibitor with Potent Antitumor Activity. PLoS ONE. 10(12). e0144675–e0144675. 26 indexed citations
11.
Ohashi, Akihiro, Momoko Ohori, Kenichi Iwai, et al.. (2015). Aneuploidy generates proteotoxic stress and DNA damage concurrently with p53-mediated post-mitotic apoptosis in SAC-impaired cells. Nature Communications. 6(1). 7668–7668. 132 indexed citations
12.
Sakao, Kozue, et al.. (2015). Anticancer activity of an extract of <i>Cordyceps militaris</i> soaked in sweetpotato <i>shochu</i> in human leukemia cells. JOURNAL OF THE BREWING SOCIETY OF JAPAN. 110(6). 444–452. 1 indexed citations
13.
Uchino, Shigehiko, et al.. (2014). Impact of withdrawing antithrombin III administration from management of septic patients with or without disseminated intravascular coagulation. Blood Coagulation & Fibrinolysis. 25(8). 795–800. 3 indexed citations
14.
Hirayama, Takaharu, Masanori Okaniwa, Takashi Imada, et al.. (2013). Synthetic studies of centromere-associated protein-E (CENP-E) inhibitors: 1.Exploration of fused bicyclic core scaffolds using electrostatic potential map. Bioorganic & Medicinal Chemistry. 21(17). 5488–5502. 20 indexed citations
15.
Sumi, Hiroyuki, Masato Yabuki, Kenichi Iwai, et al.. (2012). Antitumor Activity and Pharmacodynamic Biomarkers of a Novel and Orally Available Small-Molecule Antagonist of Inhibitor of Apoptosis Proteins. Molecular Cancer Therapeutics. 12(2). 230–240. 12 indexed citations
16.
Fujiwara, Takashi, et al.. (2011). Demonstration tests of sweet potato-<i>shochu</i> making technology with the long-term repetition of <i>sashimoto</i> and reuse of stillage for fermentation. JOURNAL OF THE BREWING SOCIETY OF JAPAN. 106(9). 611–619. 1 indexed citations
18.
Kase, Yoichi, Toru Obata, Kenichi Iwai, et al.. (2008). Removal of 2‐Arachidonylglycerol by Direct Hemoperfusion Therapy With Polymyxin B Immobilized Fibers Benefits Patients With Septic Shock. Therapeutic Apheresis and Dialysis. 12(5). 374–380. 21 indexed citations
19.
Boonanuntanasarn, Surintorn, Goro Yoshizaki, Kenichi Iwai, & Toshio Takeuchi. (2004). Molecular Cloning, Gene Expression in Albino Mutants and Gene Knockdown Studies of Tyrosinase mRNA in Rainbow Trout. Pigment Cell Research. 17(4). 413–421. 54 indexed citations
20.
Nakamura, Kazutaka, Akiyuki Ozaki, Kenichi Iwai, et al.. (2001). Genetic mapping of the dominant albino locus in rainbow trout (Oncorhynchus mykiss). Molecular Genetics and Genomics. 265(4). 687–693. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026